Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Correlation of Circadian Rhythms and Improvement of Depressive Symptoms in Acute Ischemic Stroke Patients

Author(s): Yue Ding, Shengnan Chen, Qian Sun, Fei Han, Rui Chen and Jie Li*

Volume 21, Issue 1, 2024

Published on: 25 January, 2024

Page: [15 - 24] Pages: 10

DOI: 10.2174/0115672026288134231228091756

Price: $65

Abstract

Objectives: To investigate the correlation between evening melatonin timing secretion, dim light melatonin onset (DLMO), and post-stroke depression (PSD) in acute ischemic stroke patients and their influence on the improvement of depressive symptoms.

Materials and Methods: 120 patients with a recent magnetic resonance imaging confirmed stroke were included. Salivary melatonin samples were collected at 5 time points within 1 week after hospitalization (7 p.m.-11 p.m., 1 sample per hour). The circadian phase was defined by calculating DLMO secretion. Post-stroke depressive symptoms were evaluated by the 17-item Hamilton Rating Scale for Depression (HRSD) both on day 7 of hospitalization and 3 months after stroke. Patients were divided into PSD and non-PSD groups based on whether the acute phase HRSD score was ≥8. Similarly, patients were divided into the improved depressive symptoms (IDS) and no improvement in depressive symptoms (non-IDS) groups based on whether the HRSD score at 3 months was lower than at baseline. Neurological recovery at 3 months was assessed using the modified Rankin Scale (mRS).

Results: The difference in DLMO between PSD and non-PSD patients was not statistically significant (p =0.173). In the non-IDS group, there was a significant decrease in melatonin secretion at 10 p.m. (p =0.012), and DLMO was significantly later than in the IDS group (p =0.017). Logistic regression analysis showed that DLMO (OR 1.91, 95%CI:1.13-3.23, p = 0.016) was an independent risk factor for persistent no improvement in depressive symptoms, which was associated with a markedly worse prognosis (p <0.001).

Conclusion: Our findings suggest possible interventions for the very early identification of non- IDS patients.

« Previous Next »
[1]
Villa RF, Ferrari F, Moretti A. Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacol Ther 2018; 184: 131-44.
[http://dx.doi.org/10.1016/j.pharmthera.2017.11.005] [PMID: 29128343]
[2]
Guo J, Wang J, Sun W, Liu X. The advances of post-stroke depression: 2021 update. J Neurol 2022; 269(3): 1236-49.
[http://dx.doi.org/10.1007/s00415-021-10597-4] [PMID: 34052887]
[3]
Sun S, Li Z, Xiao Q, Tan S, Hu B, Jin H. An updated review on prediction and preventive treatment of post-stroke depression. Expert Rev Neurother 2023; 23(8): 721-39.
[http://dx.doi.org/10.1080/14737175.2023.2234081] [PMID: 37427452]
[4]
Wang Y, Liao X, Wang C, et al. Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: Design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry. Stroke Vasc Neurol 2021; 6(1): 139-44.
[http://dx.doi.org/10.1136/svn-2020-000359] [PMID: 32665365]
[5]
Ruan W, Yuan X, Eltzschig HK. Circadian rhythm as a therapeutic target. Nat Rev Drug Discov 2021; 20(4): 287-307.
[http://dx.doi.org/10.1038/s41573-020-00109-w] [PMID: 33589815]
[6]
Adamczak-Ratajczak A, Kupsz J, Owecki M, et al. Circadian rhythms of melatonin and cortisol in manifest Huntington’s disease and in acute cortical ischemic stroke. J Physiol Pharmacol 2017; 68(4): 539-46.
[PMID: 29151070]
[7]
Tonon AC, Constantino DB, Amando GR, et al. Sleep disturbances, circadian activity, and nocturnal light exposure characterize high risk for and current depression in adolescence. Sleep 2022; 45(7): zsac104.
[http://dx.doi.org/10.1093/sleep/zsac104] [PMID: 35522984]
[8]
Mondin TC, Cardoso TA, Souza LDM, et al. Mood disorders and biological rhythms in young adults: A large population-based study. J Psychiatr Res 2017; 84: 98-104.
[http://dx.doi.org/10.1016/j.jpsychires.2016.09.030] [PMID: 27716514]
[9]
Melo MCA, Abreu RLC, Linhares Neto VB, de Bruin PFC, de Bruin VMS. Chronotype and circadian rhythm in bipolar disorder: A systematic review. Sleep Med Rev 2017; 34: 46-58.
[http://dx.doi.org/10.1016/j.smrv.2016.06.007] [PMID: 27524206]
[10]
de Leeuw M, Verhoeve SI, van der Wee NJA, van Hemert AM, Vreugdenhil E, Coomans CP. The role of the circadian system in the etiology of depression. Neurosci Biobehav Rev 2023; 153: 105383.
[http://dx.doi.org/10.1016/j.neubiorev.2023.105383] [PMID: 37678570]
[11]
Aggestrup AS, Svendsen SD, Præstegaard A, Løventoft P, Nørregaard L, Knorr UB, et al. Circadian reinforcement therapy in combination with electronic self-monitoring facilitates a safe post-discharge period for patients with major depression. JMIR Ment Health 2023; 19(1): 124.
[http://dx.doi.org/10.2196/50072] [PMID: 37800194]
[12]
Yu SY, Sun Q, Chen S, et al. Circadian rhythm disturbance in acute ischemic stroke patients and its effect on prognosis. Cerebrovasc Dis 2023; 1-14.
[http://dx.doi.org/10.1159/000528724] [PMID: 37423205]
[13]
Keijzer H, Smits MG, Peeters T, Looman CWN, Endenburg SC, Gunnewiek JMTK. Evaluation of salivary melatonin measurements for dim light melatonin onset calculations in patients with possible sleep-wake rhythm disorders. Clin Chim Acta 2011; 412(17-18): 1616-20.
[http://dx.doi.org/10.1016/j.cca.2011.05.014] [PMID: 21601566]
[14]
Pandi-Perumal SR, Smits M, Spence W, et al. Dim light melatonin onset (DLMO): A tool for the analysis of circadian phase in human sleep and chronobiological disorders. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(1): 1-11.
[http://dx.doi.org/10.1016/j.pnpbp.2006.06.020] [PMID: 16884842]
[15]
Rahman SA, Kayumov L, Tchmoutina EA, Shapiro CM. Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome. Sleep Med 2009; 10(5): 549-55.
[http://dx.doi.org/10.1016/j.sleep.2008.03.020] [PMID: 18725185]
[16]
Leibenluft E, Feldman-Naim S, Turner EH, Schwartz PJ, Wehr TA. Salivary and plasma measures of dim light melatonin onset (DLMO) in patients with rapid cycling bipolar disorder. Biol Psychiatry 1996; 40(8): 731-5.
[http://dx.doi.org/10.1016/0006-3223(95)00488-2] [PMID: 8894065]
[17]
Gibbons RD, Clark DC, Kupfer DJ. Exactly what does the Hamilton depression rating scale measure? J Psychiatr Res 1993; 27(3): 259-73.
[http://dx.doi.org/10.1016/0022-3956(93)90037-3] [PMID: 8295158]
[18]
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4): 695-9.
[http://dx.doi.org/10.1111/j.1532-5415.2005.53221.x] [PMID: 15817019]
[19]
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28(2): 193-213.
[http://dx.doi.org/10.1016/0165-1781(89)90047-4] [PMID: 2748771]
[20]
Manni R, Cremascoli R, Perretti C, et al. Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity. Sleep Med 2019; 63: 122-6.
[http://dx.doi.org/10.1016/j.sleep.2019.04.018] [PMID: 31622953]
[21]
Duarte Faria A, Cardoso TA, Campos Mondin T, et al. Biological rhythms in bipolar and depressive disorders: A community study with drug-naïve young adults. J Affect Disord 2015; 186: 145-8.
[http://dx.doi.org/10.1016/j.jad.2015.07.004] [PMID: 26241662]
[22]
Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother 2014; 60(1): 61.
[http://dx.doi.org/10.1016/j.jphys.2013.12.012] [PMID: 24856948]
[23]
Broderick JP, Adeoye O, Elm J. Evolution of the modified rankin scale and its use in future stroke trials. Stroke 2017; 48(7): 2007-12.
[http://dx.doi.org/10.1161/STROKEAHA.117.017866] [PMID: 28626052]
[24]
Cosin C, Sibon I, Poli M, et al. Circadian sleep/wake rhythm abnormalities as a risk factor of a poststroke apathy. Int J Stroke 2015; 10(5): 710-5.
[http://dx.doi.org/10.1111/ijs.12433] [PMID: 25545189]
[25]
Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med 2019; 23(4): 2324-32.
[http://dx.doi.org/10.1111/jcmm.14170] [PMID: 30734486]
[26]
Howell SN, Griesbach GS. Sleep-wake disturbances in supra-and infratentorial stroke: an analysis of post-acute sleep architecture and apnea. Sleep Med 2021; 88: 81-6.
[http://dx.doi.org/10.1016/j.sleep.2021.10.013] [PMID: 34740169]
[27]
Cai H, Wang XP, Yang GY. Sleep disorders in stroke: An update on management. Aging Dis 2021; 12(2): 570-85.
[http://dx.doi.org/10.14336/AD.2020.0707] [PMID: 33815883]
[28]
Dong L, Brown DL, Chervin RD, Case E, Morgenstern LB, Lisabeth LD. Pre-stroke sleep duration and post-stroke depression. Sleep Med 2021; 77: 325-9.
[http://dx.doi.org/10.1016/j.sleep.2020.04.025] [PMID: 32828696]
[29]
Liu F, Yang Y, Wang S, et al. Impact of sleep duration on depression and anxiety after acute ischemic stroke. Front Neurol 2021; 12: 630638.
[http://dx.doi.org/10.3389/fneur.2021.630638] [PMID: 33841304]
[30]
Itani O, Jike M, Watanabe N, Kaneita Y. Short sleep duration and health outcomes: A systematic review, meta-analysis, and meta-regression. Sleep Med 2017; 32: 246-56.
[http://dx.doi.org/10.1016/j.sleep.2016.08.006] [PMID: 27743803]
[31]
Koo DL, Nam H, Thomas RJ, Yun CH. Sleep disturbances as a risk factor for stroke. J Stroke 2018; 20(1): 12-32.
[http://dx.doi.org/10.5853/jos.2017.02887] [PMID: 29402071]
[32]
Zhao F, Yue Y, Li L, et al. Clinical practice guidelines for post-stroke depression in China. Rev Bras Psiquiatr 2018; 40(3): 325-34.
[http://dx.doi.org/10.1590/1516-4446-2017-2343] [PMID: 29412338]
[33]
Meng H, Liu T, Borjigin J, Wang MM. Ischemic stroke destabilizes circadian rhythms. J Circadian Rhythms 2008; 6(0): 9.
[http://dx.doi.org/10.1186/1740-3391-6-9] [PMID: 18922153]
[34]
Voultsios A, Kennaway DJ, Dawson D. Salivary melatonin as a circadian phase marker: Validation and comparison to plasma melatonin. J Biol Rhythms 1997; 12(5): 457-66.
[http://dx.doi.org/10.1177/074873049701200507] [PMID: 9376644]
[35]
Sun W, Miao J, Song Y, et al. Systemic low-grade inflammation and depressive symptomology at chronic phase of ischemic stroke: The chain mediating role of fibrinogen and neutrophil counts. Brain Behav Immun 2022; 100: 332-41.
[http://dx.doi.org/10.1016/j.bbi.2021.10.011] [PMID: 34728390]
[36]
Pawluk H, Kołodziejska R, Grześk G. Increased oxidative stress markers in acute ischemic stroke patients treated with thrombolytics. Int J Mol Sci 2022; 23(24): 15625.
[http://dx.doi.org/10.3390/ijms232415625] [PMID: 36555265]
[37]
Sletten TL, Magee M, Murray JM, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial. PLoS Med 2018; 15(6): e1002587.
[http://dx.doi.org/10.1371/journal.pmed.1002587] [PMID: 29912983]
[38]
Yawoot N, Govitrapong P, Tocharus C, Tocharus J. Ischemic stroke, obesity, and the anti‐inflammatory role of melatonin. Biofactors 2021; 47(1): 41-58.
[http://dx.doi.org/10.1002/biof.1690] [PMID: 33135223]
[39]
Yao D, Li R, Hao J, et al. Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. Transl Psychiatry 2023; 13(1): 310.
[http://dx.doi.org/10.1038/s41398-023-02614-z] [PMID: 37802998]
[40]
Gunata M, Parlakpinar H, Acet HA. Melatonin: A review of its potential functions and effects on neurological diseases. Rev Neurol 2020; 176(3): 148-65.
[http://dx.doi.org/10.1016/j.neurol.2019.07.025] [PMID: 31718830]
[41]
Maiese K. Cognitive impairment and dementia: Gaining insight through circadian clock gene pathways. Biomolecules 2021; 11(7): 1002.
[http://dx.doi.org/10.3390/biom11071002] [PMID: 34356626]
[42]
Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: The role of melatonin. Nutrients 2021; 13(10): 3480.
[http://dx.doi.org/10.3390/nu13103480] [PMID: 34684482]
[43]
Robinson RG, Price TR. Post-stroke depressive disorders: A follow-up study of 103 patients. Stroke 1982; 13(5): 635-41.
[http://dx.doi.org/10.1161/01.STR.13.5.635] [PMID: 7123596]
[44]
Vataja R, Pohjasvaara T, Leppävuori A, et al. Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry 2001; 58(10): 925-31.
[http://dx.doi.org/10.1001/archpsyc.58.10.925] [PMID: 11576030]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy